Osteoporosis

Area of Science:

• Endocrinology
• Geriatrics
• Public Health

Background:

• Osteoporotic fractures are a significant cause of morbidity and mortality.
• Effective management strategies are crucial for at-risk populations, including postmenopausal women, men, and individuals with glucocorticoid-induced osteoporosis.

Purpose of the Study:

• To provide an updated overview of clinical osteoporosis management.
• To emphasize the role of comprehensive fracture risk assessment beyond bone densitometry.
• To discuss the application of risk-assessment tools and available pharmacotherapies.

Main Methods:

• Review of current clinical practices in osteoporosis.
• Evaluation of bone densitometry's contribution to fracture risk assessment.
• Analysis of epidemiologically derived risk-assessment tools, such as the World Health Organization Fracture Risk Assessment Tool (FRAX).

Main Results:

• Fracture risk assessment, incorporating multiple factors, is key for patient evaluation.
• Tools like FRAX aid in identifying individuals who would benefit from osteoporosis therapy.
• Pharmacological treatments can significantly reduce fracture incidence.

Conclusions:

• A multifaceted approach to osteoporosis management, integrating risk assessment and targeted therapies, is essential.
• Advances in osteoporosis treatment demonstrate successful translation of research into clinical practice.
• Early identification and intervention can mitigate the substantial burden of osteoporotic fractures.